What Is Obesity? Adiposity, BMI and Why It's a Disease

Obesity is about body fat and its effects — not the scale

Weight on a scale combines muscle, bone, water, organs and fat. Obesity refers specifically to excess or dysfunctional adipose (fat) tissue that impairs health. Two people at the same weight can carry very different amounts of fat, distributed very differently, with very different metabolic consequences. The distinction is not academic: it decides whether a given weight needs treatment at all, and if so, which treatment.

Modern definitions increasingly frame obesity as "adiposity-based chronic disease" — a term from the American Association of Clinical Endocrinology that moves the focus from a number to the tissue and its effects. A 2025 Lancet Diabetes & Endocrinology Commission proposed a further distinction between clinical obesity (excess adiposity that is already causing organ dysfunction or limiting daily function) and preclinical obesity (excess adiposity with preserved function but higher future risk). Both anchor the diagnosis to health rather than to weight.

The vocabulary, briefly

• Overweight / obesity — categories usually defined by BMI, used for screening.
• Adiposity — the amount of fat tissue itself.
• Visceral fat — fat around the abdominal organs; the most metabolically active, and the most closely linked to diabetes, fatty liver and cardiovascular risk.
• Subcutaneous fat — fat under the skin; less metabolically harmful, and in some depots (hips and thighs) possibly protective.
• Ectopic fat — fat stored where it does not belong: liver (steatosis, leading to MASLD), muscle, pancreas, heart. Often the real driver of metabolic dysfunction.
• Metabolic dysfunction — the downstream consequences: insulin resistance, high triglycerides, high blood pressure, fatty liver, higher glucose.

BMI: useful for populations, blunt for individuals

BMI (weight ÷ height²) is a cheap, reproducible screening tool that correlates with body fat across large groups, which is why guidelines still use it. As a measure of one individual it has real limits:

• It does not distinguish fat from muscle. A muscular person can have a high BMI with low body fat.
• It ignores fat distribution. Two people with BMI 31 can have very different visceral fat.
• It performs differently across ethnicities. Cardiometabolic risk rises at lower BMI in South Asian, East Asian and some other populations, which is why lower thresholds are used in those groups.
• It misses "normal-weight obesity" — normal BMI with a high body-fat percentage and metabolic risk.
• It can mislabel "sarcopenic obesity" — high fat with low muscle, common in older adults and sometimes hidden at a normal BMI.

None of this makes BMI worthless. Measured consistently, it tracks adiposity well enough across a population to identify who should be looked at more closely, and it is available in every clinic at no cost. The remedy is context rather than abandonment: waist circumference (or waist-to-height ratio) and, where it changes management, body composition and metabolic labs. Guidelines from AACE, the Obesity Medicine Association and others increasingly pair BMI with waist measurement and a complications-based assessment rather than using BMI alone.

Obesity staging

Staging systems such as the Edmonton Obesity Staging System (EOSS) grade obesity by the actual medical, functional and psychological burden rather than by BMI. Someone with BMI 33 and no complications (EOSS 0–1) is in a different clinical situation from someone with BMI 33, diabetes, fatty liver and sleep apnea (EOSS 2–3). Staging predicts outcomes better than BMI and determines how aggressively treatment is considered. It is the operational form of treating the person rather than the scale. → How Obesity Should Be Evaluated

Visceral fat, ectopic fat, and "metabolically healthy" obesity

The most consequential fat is usually the fat that cannot be pinched. Visceral and ectopic fat — around and inside organs — drive insulin resistance, fatty liver and cardiovascular risk considerably more than subcutaneous fat does.

"Metabolically healthy obesity" (MHO) describes people with obesity but normal blood pressure, glucose and lipids and no fatty liver. The state is real, with two qualifications. It is often transient: many people classified as MHO develop metabolic disease over years of follow-up. And even with normal metabolic labs, obesity carries mechanical and long-term risks, including osteoarthritis, sleep apnea, some cancers and atrial fibrillation.

"Metabolically healthy" is therefore better read as lower-risk at present than as free of risk, which argues for monitoring rather than either alarm or reassurance. The same logic runs the other way: metabolic dysfunction found at a modest BMI is still metabolic dysfunction, and is treated as such. → Obesity & Cardiovascular Health

Why obesity is a chronic disease, and why weight is "defended"

The clearest evidence that obesity is biologically regulated rather than a matter of willpower is what happens after weight loss. The body behaves as though defending a set point:

• Appetite hormones shift toward hunger. Ghrelin, a hunger signal, rises while satiety signals fall, and these changes can persist for a year or more after weight loss.
• Energy expenditure falls more than predicted for the new, smaller body — adaptive thermogenesis.
• Food becomes more rewarding, which makes the reduced-weight state harder to hold.

Each of these responses is measurable, and together they act in the same direction: to restore the weight that was lost. They are also the reason that treatment is judged while it is being used rather than after it is stopped, in the same way blood pressure control is judged while the medication is being taken.

These responses are coordinated, involuntary and physiological. They explain why most people regain weight after dieting, and why regain is biology rather than a moral or treatment failure. They also place obesity treatment in the category of chronic-disease management, like hypertension, where stopping effective treatment predictably reverses the benefit. → Why Is Weight So Hard to Lose? · Weight Regain & Maintenance

Can obesity be "cured"?

For most people obesity behaves like a chronic, relapsing condition that can be controlled rather than permanently cured. Behavioral, pharmacologic and surgical treatment can all produce large, durable improvements in weight and health while treatment continues. Bariatric surgery gives the most durable results and induces long-term diabetes remission in a substantial minority, but even surgery is not a guaranteed permanent cure, and some regain is normal.

Framing success as cure or failure sets patients up to be defeated by ordinary biology. The more useful question is how much health improvement can be achieved and sustained with the least burden. In our practice that question, applied to one person's adiposity, metabolic findings and goals, is what the first consultation is for.

Questions patients ask

Written by Darius A. Schneider, MD, PhD · Board-Certified Endocrinologist (ECNU) · Last updated: Oct 2026 · References: AACE/ACE adiposity-based chronic disease framework; Obesity Medicine Association; Lancet Diabetes & Endocrinology Commission on Clinical Obesity (2025); Edmonton Obesity Staging System.